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Abstract
Background: Control of the global burden of tuberculosis is obstructed due to lack of simple, rapid and cost effective
diagnostic techniques that can be used in resource poor-settings.
To facilitate the early diagnosis of TB directly from clinical specimens, we have standardized and validated the use
of nested multiplex PCR, targeting gene fragments IS6110, MTP40 and 32kD α-antigen encoding genes specific for
Mycobacterium tuberculosis complex and non-tubercular mycobacteria (NTM), in comparison to smear microscopy,
solid culture and single step multiplex PCR. The results were evaluated in comparison to a composite reference
standard (CRS) comprising of microbiological results (smear and culture), clinical, radiological and cytopathological
findings, clinical treatment and response to anti-tubercular therapy.
Methods: The nested multiplex PCR (nMPCR) assay was evaluated to test its utility in 600 (535 pulmonary and 65
extra-pulmonary specimens) clinically suspected TB cases. All specimens were processed for smear, culture, single
step multiplex PCR and nested multiplex PCR testing.
Results: Out of 535 screened pulmonary and 65 extra-pulmonary specimens, 329 (61.5 %) and 19 (29.2 %) cases
were culture positive for M. tuberculosis. Based on CRS, 450 patients had “clinical TB” (definitive-TB, probable-TB
and possible-TB). Remaining 150 were confirmed “non-TB” cases. For culture, the sensitivity was low, 79.3 % for
pulmonary and 54.3 % for extra-pulmonary cases. The sensitivity and specificity results for nMPCR test were
evaluated taken composite reference standard as a gold standard. The sensitivity of the nMPCR assay was 97.1 % for
pulmonary and 91.4 % for extra-pulmonary TB cases with specificity of 100 % and 93.3 % respectively.
Conclusion: Nested multiplex PCR using three gene primers is a rapid, reliable and highly sensitive and specific
diagnostic technique for the detection and differentiation of M. tuberculosis complex from NTM genome and will
be useful in diagnosing paucibacillary samples. Nested multiplex PCR assay was found to be better than single
step multiplex PCR for assessing the diagnosis of TB.
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Background
Tuberculosis (TB), caused by Mycobacterium tubercu-
losis complex (MTBC), still remains the major killer
disease worldwide, especially in developing countries in
spite of considerable progress in diagnosis and treatment
[1]. Mycobacterium tuberculosis complex comprises of
Mycobacterium tuberculosis (MTB), M. africanum, M.
canettii, M. bovis, M. microti, M. orygis, M. caprae, M.
pinnipedii, M. suricattae and recently recognized M.
mungi [2]. According to WHO there were approximately
9.0 million new cases and 1.5 million deaths globally in
2014. India contributed the highest number of new cases
of TB, accounting for 24 % of the global burden [1].
Extra-pulmonary tuberculosis (EPTB) contributes about
15–20 % of the total cases of tuberculosis worldwide [1].
A major obstacle to the diagnosis of EPTB is the atypical
presentation, often simulating neoplasia and/or inflam-
matory disorders.
The non-tuberculous mycobacterial (NTM) infections
have also increased in many regions of the world along
with MTBC infections and much of this increase in the
burden of TB concurred with human immune deficiency
virus (HIV) infection in patients [3, 4]. The species of
NTM associated with human disease are: M. avium, M.
intracellulare, M. kansasii, M. fortuitum, M. chelonae,
M. szulgai, M. paratuberculosis, M. scrofulaceum etc.
Most of the incidence of NTM infections has been re-
ported from TB non-endemic countries and rarely from
TB endemic countries because the chances of missing
NTM infection are higher in TB endemic countries [5, 6].
The current standard of care for diagnostic techniques
does not include bacterial characterization. Consequently,
some NTM cases with positive smears will continue to be
misclassified as MTB and receive chemotherapy com-
monly used for tuberculosis due to which some of the
NTM strains may be resistant. Hence, majority of NTM
infections will remain undetected. In addition, cases of
mixed infection have also been reported [4, 7].
The conventional methods such as smear microscopy
has low sensitivity and specificity and culture is time
consuming (6–8 weeks) because of the slow growth rate
of TB bacilli [7–9]. To overcome these problems, nucleic
acid amplification test (NAAT) has been used for diagno-
sis of pulmonary tuberculosis (PTB) and extra-pulmonary
tuberculosis [10]. In case of extra-pulmonary specimens
there is a lack of sensitivity of conventional PCR tech-
niques as they are mostly paucibacillary in nature. Another
major limitation of single step PCR for pulmonary and
extra-pulmonary specimens is the presence of PCR inhibi-
tors that inhibit the amplification based techniques. There-
fore, a two step process is necessary to eliminate/dilute the
inhibitors present in the clinical specimens.
The target sequences IS6110 and MTP40 have been
used in multiplex PCR for the diagnosis of pulmonary
and extra-pulmonary TB which increases the sensitivity
for detection [11–15]. One study has reported a robust,
reproducible and uniform nested PCR (nPCR) protocol
for the removal of PCR inhibitors, but nested PCR lacks
the specificity by using single target sequence [16]. Some
studies have also compared nucleic acid amplification
test with composite reference standard (CRS) and cul-
ture [17–19], but these techniques could not differenti-
ate MTBC from NTM. Therefore, we have used nested
multiplex PCR (nMPCR) assay and compared it with
composite reference standard and single step multiplex
PCR (mPCR) assay to evaluate the true diagnostic po-
tential of the nMPCR assay for pulmonary and extra-
pulmonary TB. The CRS for this study comprised of signs,
symptoms, radiological scans, cytolopathology, microbio-
logical results (smear and LJ culture), previous and family
history and response to anti-tubercular therapy (ATT).
Methods
Study design
This study was conducted during the period May 2012 -
February 2014 at the Department of Microbiology, Institute
of Medical Sciences, Banaras Hindu University, Varanasi,
India. The patients registered in this study were attending
either outpatient department or were admitted in the ward,
Department of Chest and Respiratory diseases, Sir Sunder
Lal Hospital, Institute of Medical Sciences, Banaras Hindu
University.
Specimen collection
A total of 600 clinical specimens were studied, including
535 pulmonary [523 sputum and 12 Bronchoalveolar
Lavage (BAL)] and 65 extra-pulmonary specimens from
outpatients and inpatients of a tertiary care centre of
Banaras Hindu University, Varanasi. The 65 extra-
pulmonary specimens included 15 sterile body fluids
(5 pleural fluid, 9 cerebrospinal fluid (CSF) and one
blood from bone marrow), 15 pus samples, 20 urine
samples and 15 fine needle aspirates (FNAs). Each
sample was divided into two parts. First part was used for
microbiological investigations (microscopy and culture)
and second part was processed for PCR.
Clinical assessment of patients
The patients were categorized on the basis of composite
reference standard criteria.
(A)Definitive TB groups: AFB smear positive and
culture positive (S + C+) and AFB smear negative
and culture positive (S-C+),
(B) Probable TB groups: Patients’ selection with AFB
smear positive and culture negative (S + C-) but
showing clinical symptoms, chest X-ray highly
indicative of TB and/or cytology suggestive of TB,
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(C) Possible TB groups: smear negative and culture
negative (S-C-) and only clinical signs and/or
symptoms suggestive of TB; patients response to
ATT and
(D)Non-TB groups: microbiological tests for TB were
negative and patient improved without taking ATT
but two specimens were obtained from patients
with lymphadenopathy and metastatic carcinoma.
Sample preparation
Sputum, pus and BAL (bronchoalveolar Lavage) samples
were processed using Petroff ’s method (4 % NaOH)
[20]. One loopful (approximately 0.1–0.15 ml) of sterile
body fluids like pleural fluid, CSF and blood from bone
marrow were inoculated directly on Lowenstein Jensen
(LJ) medium. If the specimen volume was more than
10 ml, concentration by centrifugation was done at about
3000–3500 × g for 15–20 min [21, 22]. FNAC samples
were collected aseptically, dispensed in 200 μl phosphate
buffer saline and one loopful was directly inoculated on LJ
medium. Urine samples were concentrated by centrifuga-
tion at 3000 × g for 15 min followed by decontamination
in a similar manner as sputum [22].
Microscopy and culture
All pulmonary and extra pulmonary clinical specimens
and the sediments were subjected to smear examination
through the standard Ziehl Neelsen’s staining method
and were cultured onto a pair of Lowenstein-Jensen
slants [23]. The LJ slants were incubated at 37 °C and
inspected weekly for mycobacterial growth for a period
of 8 weeks. Cultures grown were identified by standard
biochemical tests such as nitrate reductase, heat stable
catalase and sensitivity to PNB [24, 25].
DNA extraction
DNA extraction was carried out from the processed
clinical specimens by CTAB-chloroform method [26].
The concentration of DNA was determined by measur-
ing the optical density at 260 nm by Nanodrop2000
(Thermo scientific, US). DNA used for PCRs were
diluted in Tris-EDTA buffer (pH-7.8) to final concen-
trations of less than 40 μg/ml to overcome the action of
potential PCR inhibitors.
Two step nested multiplex PCR standardization for the
IS6110, MTP40 and 32-kDα-antigen encoding gene
sequences
Two step nested multiplex PCR assay was standardized
and was found to have quantitative sensitivity to detect
the DNA equivalent to 1-2 organisms. It tested positive
with standard strain of M. tuberculosis, H37Rv. In each
independent nMPCR assay, test results were compared
with the results for one positive and one negative con-
trol. We used the reference strain H37Rv M. tuberculosis
as positive control and molecular grade water (no target
DNA) as negative control. M. tuberculosis H37Rv and
M. smegmatis standard strain had been obtained from
JALMA, Agra, India.
The identification and differentiation of MTBC from
NTM was carried out by using specific pair of primers
reported by Portillo et al. [27] to amplify IS6110, MTP40
& 32kD α-antigen encoding gene sequences (Table 1)
specific for M. tuberculosis complex, M. tuberculosis and
non-tuberculous mycobacteria respectively in single step
multiplex PCR. In nested multiplex PCR we have designed
specific pair of primers for amplification of IS6110,
MTP40 & 32kD α-antigen encoding gene sequences which
gave band sizes of 500 bp, 342 bp & 413 bp respectively
(Table 2).
The first round PCR master mix was prepared by
mixing 24 μl of a previously mixed reaction mixture
[containing 2.5 μl of 10X reaction buffer (GeNei, Banglore,
India), 2.5 μl of 200 μM concentrations of each of the
deoxynucleoside triphosphates (dNTPs) (GeNei, Banglore,
India), 0.1 μl of 5U Taq DNA Polymerase (GeNei,
Banglore, India) and 1 μl of the each oligonucleotide
primers (10 pmol) (GeNei, Banglore, India)], 5 μl of
the DNA template and added milli Q to create a total vol-
ume of 25 μl. The first-round amplification was carried
out in a thermocycler (T-100™-Bio-Rad) under the follow-
ing conditions: initial denaturation at 95 °C for 3 min,
Table 1 Sequences of primers used in the detection of Mycobacterium spp. in single step multiplex PCR assay
Genes Primers Sequence (5’-3’) Size (bp) Reference
MTP40a MTB F CGGCAACGCGCCGTCGGTGG 396 Herrera E. A. 1996 [15]
MTB R CCCCCCACGGCACCGCCGGG
IS6110b MTBC F CGGAGACGGTGCGTAAGTGG 984 Wojciech, 1992 [39]
MTBC R GATGGACCGCCAGGGCTTGC
32kD α-antigenc NTM F TTCCTGACCAGCGAGCTGCCG 506 Ohara et al., 1993 [40]
NTM R CCCCAGTACTCCCAGCTGTGC
aspecific for Mycobacterium tuberculosis
bspecific for Mycobacterium tuberculosis complex
cspecific for non-tuberculous mycobacterium
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35 cycles of 94 °C for 1 min, 65 °C for 1 min and 72 °C for
50 s and a final extension at 72 °C for 7 min. In nested
multiplex PCR, reaction mixture was same as that in first
round PCR, except it contained 15 pmol of second round
primers (Table 2) and 2 μl of 1:6 diluted product of the
primary cycle as DNA template. The amplification condi-
tions were identical to that of first round PCR. The ampli-
fied products of both cycles were analyzed by agarose gel
electrophoresis (GeNei, Banglore, India) on 2 % agarose
gel (GeNei, Banglore, India) using 5 μl of amplified
products. The gels were stained with ethidium bromide
(0.5 μg/ml) and bands were visualized under UV light.
Statistical analysis
Sensitivity, specificity, positive predictive value and nega-
tive predictive value of the nMPCR were evaluated by
using online MedCalc and compared with single step
PCR, microbiological tests and CRS.
Ethics statement
This study has been ethically approved by the ethical
committee of the Institute of Medical Sciences, Banaras
Hindu University, Varanasi, India.
Results
Clinical data
Out of 600 patients 223 (37.2 %) were females and 377
(62.8 %) were males. The participants ranged from 2 to
90 years (median age 26.3 ± 16.8). Most of the patients
[267/600; (44.5 %) were in 20–40 years age group.
Patient categories
A total of 600 patients were considered in this study.
Out of these participants, 348 (58.0 %) were culture
positive “definitive TB” cases [255 (42.5 %) being smear
positive and 93 (15.5 %) being smear negative]; 47
(7.8 %) were clinically, radiologically, and/or cytologically
positive, suggestive of “probable TB” cases; 55 (9.2 %)
were only clinically positive and responded to ATT,
suggestive of “possible TB” cases; and 150 (25 %) pa-
tients had no evidence of TB and were “non-TB” cases.
Details of study participations are depicted in Fig. 1 of
450 specimens, 92.2 % (n = 415) pulmonary and 7.8 %
(n = 35) extra-pulmonary specimens were able to fit the
CRS criteria as reference.
Culture and microscopy
Out of 535 pulmonary samples, 53.6 % (n = 287) were
positive for AFB bacilli whereas 61.5 % (n = 329) samples
were positive for MTB culture. Of the 65 extra-pulmonary
specimens 3.1 % (n = 2) pleural fluid, 4.6 % (n = 3) CSF,
9.2 % (n = 6) pus and 6.1 % (n = 4) FNAs were positive by
Ziehl-Neelsen staining, while 4.6 % (n = 3) pleural
fluid, 6.1 % (n = 4) CSF, 1.5 % (n = 1) bone marrow,
10.8 % (n = 7) pus and 6.1 % (n = 4) FNAs were culture
positive (Table 3). From 600 specimens, 50.3 % (302/600)
were AFB smear positive, 344 (57.3 %) were M. tubercu-
losis culture positive, 4 (0.7 %) were NTM positive and
241 (40.2 %) were culture negative. Eleven (1.8 %) were
contaminated. Finally 348 specimens were mycobacteria
culture positive which was considered in the final analysis.
Evaluation of nested multiplex PCR
The results obtained by nMPCR for pulmonary and extra-
pulmonary specimens are shown in Table 3. On subjecting
all the clinical specimens to nMPCR, 75.3 % (403/535)
pulmonary and 49.2 % (32/65) extra-pulmonary samples
were positive for either or all the target genes namely
IS6110, MTP40 and 32kD-α antigen. The gel picture is
shown in Fig. 2. Further, detection of TB increased from
60.8 % (365/600) by single step mPCR to 72.5 % (435/600)
by nMPCR for clinical specimens. In addition, with regard
to PCR target detection in the nested multiplex PCR
protocol, 87.8 % [including 69.7 % (373/535) pulmonary
and 33.8 % (22/65) extra-pulmonary specimens] of the
450 clinically confirmed and suspected TB cases showed
both IS6110 and MTP40 amplified bands patterns which
belongs to the MTBC and MTB. Further, 1.1 % (6/535)
pulmonary and 1.5 % (1/65) extra-pulmonary (pus)
samples were positive for MTP40 and 32kD α-antigen
encoding gene (mixed infection) and 0.8 % (4/450)
cases were positive for 32kD α-antigen encoding gene,
Table 2 Sequences of primers used in nested multiplex PCR for the detection of Mycobacterium spp.
Genes Primers Sequence (5’-3’) Size (bp) Reference (Primers)
nMTP40a MTB2F CGTTCGGGATGCACTGCG 342 In this study
MTB2R CACCCGGCGAATTCGTCAC
nIS6110b MTBC2F CGATCGCCCCATCGACCTACT 500 In this study
MTBC2R GGTCGAGTACGCCTTCTTGT
n32kD α-antigenc NTM2F CACCCGCAGTTCATCTA 413 In this study
NTM2R CGTTGTAGGCGTCCTGG
n Primers used in nested PCR
aspecific for Mycobacterium tuberculosis
bspecific for Mycobacterium tuberculosis complex
cspecific for non-tuberculous mycobacterium
Sinha et al. BMC Infectious Diseases  (2016) 16:123 Page 4 of 10
IS6110 and MTP40 (mixed infection) (Fig. 3). No indi-
vidual sample was established by culture to harbour
both M. tuberculosis and non tubercular mycobacteria,
as was seen with samples examined by the nMPCR assay.
Among 450 TB cases, only IS6110 band pattern was
detected in 1.5 % (n = 7) samples including 4 sputum, 1
BAL, 1 pus and 1 FNA and only MTP40 band was de-
tected in 2.0 % (n = 9) samples including 7 sputum, 1 CSF
and 1 pus. Only 32kD α-antigen encoding gene band pat-
tern was obtained in 2.9 % (13/450) specimens.
Of the 150 samples (control), from those patients without
mycobacterial infections, 98.7 % (n = 148) samples were
found to be nested multiplex PCR negative, as expected;
whereas, remaining 1.3 % (n = 2) samples were positive for
both IS6110 and MTP40 band patterns (Table 3).
Diagnostic association of nMPCR results with composite
reference standard criteria
Table 4 represent the association of nMPCR and single
step mPCR with CRS in clinical specimens. Among the
S + C+ specimens (Group A), single step mPCR and
nMPCR assay detected mycobacterial DNA in 92.9 %
(237/255) and 100 % (255/255) of specimens respectively.
Among the S-C+ specimens (Group A), 77.4 % (72/93)
specimens were single step mPCR positive and 98.9 %
(92/93) were positive for nMPCR assay. From this group
8.6 % (22/255) and 15.3 % (39/255) of the samples were
single step mPCR positive for only MTP40 and IS6110
band patterns but in nMPCR only 3.5 % (9/255) and 2.3 %
(6/255) of the specimens were positive for only MTP40
and IS6110 respectively (Additional file 1).
Out of 47 S + C- specimens (Group B) 66.0 % (n = 31)
were single step mPCR positive and 95.7 % (n = 45) were
positive for nMPCR. On the other hand, 45.4 % (25/55)
and 78.2 % (43/55) of the S-C- specimens were positive
for single step PCR and nMPCR assay respectively
(Table 4). There details for specific band patterns are
shown in additional file 1. Finally, out of 150 samples
taken from patients without mycobacterial infection, 148
(included in Group D) were found to be negative for
both single step mPCR and nMPCR whereas, remaining
2 (1.3 %) samples were positive for nMPCR assay but
negative in single step mPCR.
There were 9 samples in group A which showed
absence of IS6110 and presence of MTP40 band pat-
tern in nMPCR assay indicating presence of M. tuber-
culosis strains lacking IS6110 gene sequence. Besides,
some specimens from group A and B showed presence
of members of MTBC other than M. tuberculosis
(Additional file 1).
Fig. 1 Flow chart of the participants included and analyzed in this study
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Table 3 Comparison of smear, culture, single step mPCR and nMPCR for detection of Mycobacterium spp. in clinical samples




























373 (69.7) 6 (1.1) 5 (0.9) 7 (1.3) 9 (1.7) 3 (0.6)




365 (69.8) 6 (1.1) 4 (0.8) 7 (1.3) 9 (1.7) 3 (0.6)
BAL 12 6 (50) 4 (33.3) 6 (50) 8 (66.6) 9 (75) 8 (66.6) 0 1 (0.2) 0 0 0
Extra-pulmonary
samples
65 35 (53.8) 15 (23.1) 19 (29.2) 20 (30.8) 32 (49.2) 22 (33.8) 1 (1.5) 2 (3.0) 2 (3.0) 4 (6.1) 1 (1.5)
Pleural Fluid 5 3 (60) 2 (40) 3 (60) 3 (60) 3 (60) 3 (60) 1 0 0 0 0
CSF 9 6 (66.7) 3 (33.3) 4 (44.4) 4 (44.4) 5 (55.5) 4 (44.4) 0 0 1 (11.1) 0 0
Bone marrow 1 1 (100) 0 1 (100) 1 (100) 1 (100) 1 (100) 0 0 0 0 0
Pus 15 12 (80) 6 (40) 7 (46.7) 6 (40) 12 (80) 7 (46.7) 1 (6.7) 1 (6.7) 1 (6.7) 1 (6.7) 1 (6.7)
Urine 20 4 (20) 0 0 1 (5) 3 (15) 3 (15) 0 0 0 0 0
FNAs 15 9 (60) 4 (26.7) 4 (26.7) 5 (33.3) 8 (53.3) 4 (26.7) 0 1 (6.7) 0 3 (20) 0




395 (87.8) 7 (1.5) 7 (1.5) 9 (2.0) 13 (2.9) 4 (1.0)
Control 150 0 - - - 2 (1.3) 2 (1.3) - - - - -
Total 600 - - - - 437
(72.8)
397 (66.2) - - - - -














Performance of all tests using CRS as a gold standard
for all clinical specimens are presented in Table 5. As
can be seen, nMPCR test have higher sensitivity than
smear, culture and single step mPCR in different clinical
samples. The sensitivities of smear, culture, single step
PCR, nMPCR tests and CRS were found to be 69.2, 79.3,
83.1, 97.1 and 100 % for PTB and 42.9, 54.3, 57.1, 91.4
and 100 % for EPTB cases.
Discussion
Early identification of the infecting microorganism is ne-
cessary for patient management. In the case of MTB in-
fection, rapid diagnosis and identification is a major
factor for starting anti-TB drug therapy and to control
the dissemination of MTB bacilli from person to person.
Further, it is necessary to differentiate MTBC members
from NTM for proper management of tuberculosis. The
precise and early diagnosis of extra-pulmonary TB is
challenging due to the paucibacillary nature of the speci-
mens and requiring long incubation time for growth of
tubercle bacilli. This long delay without positive or nega-
tive microbiological results could be shortened by the
use of amplification techniques. However, these methods
have relatively low sensitivity when applied directly to
extra-pulmonary samples [28].
Therefore, we evaluated the utility of nested multiplex
PCR protocol for paucibacillary pulmonary and extra-
pulmonary specimens. The test detected mycobacterial
DNA in 99.7 % (347/348) specimens of ‘confirmed TB’
cases, including 26.4 % (92/348) of smear negative TB
cases. It was also observed that nMPCR protocol detected
mycobacterial DNA in 95.7 % (45/47) of the samples from
‘probable TB’ cases, whose culture were negative but who
had positive radiological tests and/or positive cytolo-
pathology reports. Whereas, 78.2 % (43/55) of the sam-
ples, whose smear and culture were negative from
‘possible TB’ cases but patients under ATT shedding
non-cultivable bacteria also detected by nMPCR. It has
been reported that nested PCR could detect those
mycobacteria that are non- cultivable [29]. One hun-
dred forty eight samples (non-TB cases) from patients
without mycobacterial infections were negative for CRS
criteria and nMPCR assay. It means these patients were
considered as truly negative for TB infection. Whereas,
remaining two samples from patients with metastatic
carcinoma and lymphadenopathy, who had no clinical
symptoms of TB may be false- positive result by nMPCR.
The immunosuppressive nature of a malignant lesion may
have been capable of reactivating a latent tubercular infec-
tion; hence, there may be coexistence of malignancy and
tuberculosis.
A previous study has reported highest PCR positivity
rates for pulmonary (77 %) and extra-pulmonary (11 %)
Fig. 2 Agarose gel electrophoresis of nested multiplex PCR for the
identification of Mycobacterium tuberculosis complex from clinical
samples. Lane-1: positive control (H37Rv); lane-2: clinical samples
positive for IS6110 and MTP40; Lane-3- negative control (MQ water);
Lane-4- negative clinical sample; lane-5- patient samples positive
for only IS6110and negative for MTP40
Fig. 3 Agarose gel electrophoresis showing mixed infection in single
step multiplex PCR. M- 100 bp DNA marker; lane-1, 2: clinical samples
positive for MTP40; lane-3: clinical sample positive for MTP40,
IS6110 and 32kD alpha antigen (Mixed infection); lane- 4, 5, 6 & 7:
clinical samples positive for MTP40 and IS6110
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samples using IS6110 as a specific target sequence [30].
However in some parts of the world, few strains do not
possess the IS6110 target sequence in their genome,
which may cause a false negative result and thereby de-
crease the sensitivity of the assay [31, 32]. Recently, one
study has reported 41.6 % and 36 % PCR positivity by
multiplex PCR targeting MTP40 and IS6110 respectively
[11]. Although, some studies have standardized the nested
PCR assay to detect even single bacillus in clinical samples
which have increased the sensitivity for detection of MTB,
nested PCR using single target alone could not differentiate
members of MTBC from non-tubercular mycobacteria
[33, 34]. Therefore, in this study we have used more
than two target sequences in nMPCR assay, which in-
creased the positivity (72.8 %) for detection of mycobac-
terial DNA. Mixed infection of NTM and Mycobacterium
tuberculosis was found in 0.2 % cases by Aliyu et al. [7].
We have found that 2.4 % (11/450) cases are shown mixed
infection of NTM and MTBC. Higher positivity of
nMPCR might be due to its ability to detect less amount
of target DNA (1 bacilli/μl) directly from clinical samples
even in the presence of relatively large amount of human
Table 4 Comparison of conventional procedures with single step mPCR and nested multiplex PCR for detection of Mycobacterium
spp. in different groups of clinical specimens
Type Study group No. of patients (n = 600) Single-step mPCR (%) Nested multiplex PCR (%)
Group A Definitive TB group (N = 348)
AFB smear + ve Culture + ve 255 (42.5) 237 (92.9) 255 (100)
AFB smear –ve Culture + ve 93 (15.5) 72 (77.4) 92 (98.9)
Group B Probable TB group (N = 47)
AFB smear + ve Culture –ve 47 (7.8) 31 (66.0) 45 (95.7)
Group C Possible TB group (N = 55)
AFB smear -ve Culture –ve 55 (9.2) 25 (45.4) 43 (78.2)
Group D Non-TB group (N = 150) 150 (25) 0 2 (1.3)
Total 600 365 (60.8) 437 (72.8)
+ve positive, -ve negative
Table 5 Sensitivity and specificity of conventional methods, nMPCR assay and CRS with respect to different specimens
Different testes Test results TB group Control (n = 150) Sensitivity (%) Specificity (%) PPV (%) NPV (%) CI














79.3 100 100 58.2 75.0 % – 83.1 %
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54.3 100 100 65.2 36.6 % – 71.2 %




















100 100 100 100 90.0 % to 100.0 %
PPV positive predictive value, NPV negative predictive value, TB group TB suspected patients, mPCR multiplex PCR, nMPCR nested multiplex PCR, CRS composite
reference standard
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DNA [33] and may also be due to selection of multiple
target sequences included MTP40, IS6110 and 32kD-α
antigen encoding gene in a two step reaction.
The sensitivity of nMPCR was observed to be 97.1 %
and 91.4 % with CRS criteria for pulmonary and extra-
pulmonary samples respectively which was greater than
80.2 % [17] and 91 % [18] sensitivity reported in the pre-
vious studies using multiplex PCR and nested PCR re-
spectively. Specificity of nMPCR assay was observed to
be 100 % and 93.9 % respectively for pulmonary and
extra-pulmonary TB cases with CRS criteria which were
comparable with that of 94.4 % [17] and 91 % [18] re-
ported in the previous studies. In this study we have
used more than two targets in nested multiplex PCR
protocol due to which sensitivity increased from 83.1 to
97.1 % for pulmonary and from 57.1 to 91.4 % for the
EPTB diagnosis. In group D two specimens were con-
sidered as false negative by CRS criteria but using
nMPCR assay it becomes positive. Therefore specificity
was found to be 93.3 % for nMPCR assay in extra-
pulmonary TB cases.
The low sensitivity of culture (79.3 % and 54.3 %) and
single step mPCR assay (83.1 % and 57.1 %) for PTB and
EPTB cases in comparison with that of nMPCR test
(97.1 % and 91.4 %) may be due to the fact that 86 %
(88/102) of the culture negative, nMPCR positive pa-
tients were on ATT for various time periods; unequal
distribution of mycobacteria in paucibacillary respira-
tory specimens, low number of bacterial load in extra-
pulmonary specimens and non-uniform dispersion of
microorganisms in clinical specimens causes clumping
of the microorganisms which is the most common
problem with mycobacteria [34, 35]. Moreover, nMPCR
can detect a single bacillus present in clinical speci-
mens than culture and single step mPCR [33, 36].
The limitation with nMPCR assay is that it is not able
to differentiate live from dead organisms. Hence, this
method should be recommended only for screening of
new cases but not for monitoring of patients in treat-
ment. Liquid culture (MIGIT 960) could have increased
the sensitivity as it is known to be 10 % more sensitive
[37]. Also using 4 % NaOH for decontamination is a
limitation of this study as it is known to be a harsh
decontaminant. The advantage of nested multiplex PCR
is that it improves the sensitivity and specificity using
signature nucleotides for the detection and differenti-
ation of MTBC from NTM in clinical specimens that
were even smear and culture negative. To the best of
our knowledge, although nested multiplex PCR assay
has been used for the diagnosis of pulmonary TB, there
is only one report of it being used for EPTB cases [38].
It is obvious that further evaluation is needed in order
to improve this nested multiplex PCR protocol for rou-
tine diagnosis.
Conclusions
Our study advocates that nested multiplex PCR is a
highly sensitive and specific technique for the diagnosis
of pulmonary and extra-pulmonary TB which is often
not only missed by conventional methods but also by
single-step multiplex PCR due to low bacillary load,
resulting in an unacceptable delay in initiation of therapy.
Further, it can also be used to detect samples with M.
tuberculosis strains lacking IS6110. This study also con-
cludes that the CRS criteria were better for assessing the
diagnostic accuracy of nested multiplex PCR assay.
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